Trial NCT02968810

Simvastatin in Preventing Liver Cancer in Patients With Liver Cirrhosis

This randomized phase II trial studies how well simvastatin works in preventing liver cancer
in patients with liver cirrhosis. Simvastatin may stop the growth of cancer cells by blocking
some of the enzymes needed for cell growth.

Intervention

Laboratory Biomarker Analysis, Placebo, Questionnaire Administration, Simvastatin

Condition

Cirrhosis

Investigators

Marc T. Goodman, Seema A. Khan

See list of participating sites